HbA1c adjusted by erythrocyte creatine is a useful glycemic control indicator in patients with hemolysis
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 73, 77-81
Abstract
No abstract availableKeywords
Funding Information
- Asahi Kasei Pharma (H27-j170)
This publication has 23 references indexed in Scilit:
- Glucose-6-Phosphate Dehydrogenase Deficiency Diagnosed in an Adolescent with Type 1 Diabetes Mellitus and Hemoglobin A1c Discordant with Blood Glucose MeasurementsThe Journal of Pediatrics, 2011
- Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemiaClinica Chimica Acta, 2011
- IFCC Reference System for Measurement of Hemoglobin A1c in Human Blood and the National Standardization Schemes in the United States, Japan, and Sweden: A Method-Comparison StudyClinical Chemistry, 2004
- Diabetes control and complications: the role of glycated haemoglobin, 25 years onDiabetic Medicine, 2003
- Kinetics of HbA1c, Glycated Albumin, and Fructosamine and Analysis of Their Weight Functions Against Preceding Plasma Glucose LevelDiabetes Care, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Nonenzymatic glycation: A central mechanism in diabetic microvasculopathy?Journal of Diabetic Complications, 1988
- The Glycosylation of Hemoglobin: Relevance to Diabetes MellitusScience, 1978
- Creatine and Phosphocreatine in the Human Red CellBritish Journal of Haematology, 1968
- The Effect of Age on the Creatine in Red CellsBritish Journal of Haematology, 1967